S. Berezowska

Discipline

Economies and finances (3) Sociology (2) Communication sciences (2) History, Philosophy and Sociology of Sciences (2) Psychology (1) Philosophy (1) Linguistics (1)

Type

Articles (48) Reviews (4)

Co-author

Date

Source

Keyword

Lungs (30) Patients (28) Patients (28) Human beings (25) Treatment (24) pathology (21) Pathology (21) Lungs--Cancer (21) Cancer (21) Therapeutics (19) therapy (18) tissue (16) survival (16) Survival (16) disease (14) disease (14) Tumors (13) cancer (12) Cancer (12) Evaluation (12) Cells (12) analysis (11) Expression (11) Analysis (11) Cases (10) Prognosis (10) Cases (10) Prognosis (10) evaluation (9) Diagnosis (9)

Documents written by S. Berezowska (48) | is about S. Berezowska (0)

Pathology of Surgically Resected Lung Cancers Following Neoadjuvant Therapy.
S. Berezowska et al. (Sep 1, 2024)
The role of pathologists in the diagnosis of occupational lung diseases: an expert opinion of the European Society of Pathology Pulmonary Pathology Working Group.
F. Calabrese et al.
Swiss digital pathology recommendations: results from a Delphi process conducted by the Swiss Digital Pathology Consortium of the Swiss Society of Pathology.
A. Janowczyk et al.
PatchSorter: a high throughput deep learning digital pathology tool for object labeling.
C. Walker et al. (Jun 20, 2024)
Current challenges and practical aspects of molecular pathology for non-small cell lung cancers.
P. Hofman et al.
Pulmonary squamous cell carcinoma and lymphoepithelial carcinoma - morphology, molecular characteristics and differential diagnosis.
S. Berezowska et al.
Impact of template-based synoptic reporting on completeness of surgical pathology reports.
N. Schaad et al.
Digital image analysis and artificial intelligence in pathology diagnostics-the Swiss view
S. Berezowska et al.
Pathologist Computer-Aided Diagnostic Scoring of Tumor Cell Fraction: A Swiss National Study.
A.L. Frei et al.
Spatial metabolomics identifies distinct tumor-specific and stroma-specific subtypes in patients with lung squamous cell carcinoma.
J. Wang et al. (Nov 2, 2023)
Patterns of Carbon-Bound Exogenous Compounds Impact Disease Pathophysiology in Lung Cancer Subtypes in Different Ways.
J. Shen et al. (Sep 12, 2023)
Overcoming the Interobserver Variability in Lung Adenocarcinoma Subtyping: A Clustering Approach to Establish a Ground Truth for Downstream Applications.
K. Lami et al. (Aug 1, 2023)
Neoadjuvant treatment does not influence PD-L1 expression in stage III non-small-cell lung cancer: a retrospective analysis of tumor samples from the trials SAKK 16/96, 16/00, 16/01, and 16/14.
D. König et al. (Jul 11, 2023)
Deep computational image analysis of immune cell niches reveals treatment-specific outcome associations in lung cancer.
C. Barrera et al. (Jun 1, 2023)
Integrated longitudinal analysis of adult grade 4 diffuse gliomas with long-term relapse interval revealed upregulation of TGF-β signaling in recurrent tumors.
E. Kashani et al. (Apr 6, 2023)
MEK1 drives oncogenic signaling and interacts with PARP1 for genomic and metabolic homeostasis in malignant pleural mesothelioma.
H. Yang et al. (Feb 10, 2023)
Immunogenomic analysis of human brain metastases reveals diverse immune landscapes across genetically distinct tumors.
R.R. Maas et al. (Jan 17, 2023)
The effect of neoadjuvant therapy on PD-L1 expression and CD8+lymphocyte density in non-small cell lung cancer.
P. Zens et al.
Programmed Death-Ligand 1 Expression in Lung Cancer and Paired Brain Metastases-a Single-Center Study in 190 Patients.
A. Kündig et al.
Major Pathologic Response and Prognostic Score Predict Survival in Patients With Lung Cancer Receiving Neoadjuvant Chemotherapy.
A. Pataer et al.
Image analysis reveals molecularly distinct patterns of TILs in NSCLC associated with treatment outcome.
R. Ding et al. (Jun 3, 2022)
Spatial metabolomics for evaluating response to neoadjuvant therapy in non-small cell lung cancer patients.
J. Shen et al.
The Octopus Sign-A New HRCT Sign in Pulmonary Langerhans Cell Histiocytosis.
A. Poellinger et al. (Apr 8, 2022)
The cGAS-STING pathway drives type I IFN immunopathology in COVID-19.
J.D. Domizio et al.
COVID-19 Pulmonary Pathology: The Experience of European Pulmonary Pathologists throughout the First Two Waves of the Pandemic.
F. Fortarezza et al. (Jan 1, 2022)

next